Catheter Coating Market

Market Overview

The global catheter coating market size was valued at USD 10.2 Billion in 2022. It is expected to reach USD 19.4 Billion by 2031, growing at a CAGR of 6.8% during the forecast period (2023–2031).

In addition to helping the body remove substances, catheters are inserted into a patient's body to deliver drugs or fluids. Catheters are frequently used in procedures for spinal surgery, urinary incontinence, urinary retention, and other conditions. These medical devices are inserted into the body and are vulnerable to the development of biofilms, which can cause infections like urinary tract infections. Therefore, different materials or substances are coated on catheters to prevent this infection. Hydrophilic materials, antimicrobial materials, and drug-eluting materials, among others, can be used to coat catheters so they can pass through the body with ease. Blood coagulation is prevented within the body by coating, which also affects how well catheters work.

Market Dynamics

Global Catheter Coating Market Drivers:

Growing Prevalence of Catheter-Associated Urinary Tract Infections (CAUTI)

Globally, catheter-associated urinary tract infections (CAUTI) have significantly increased recently. Over 13,000 deaths were linked to CAUTI in 2018, according to the Centers for Disease Control and Prevention. During their stay in the hospital, 15–25% of hospitalized patients use urinary catheters. Prolonged use of the urinary catheter is the leading risk factor for developing a catheter-related UTI (CAUTI). Therefore, one of the key factors driving the growth of the market is the rise of CAUTI.

Increased Use of Catheters among the Elderly Population

Catheters are frequently used in elderly patients with cancer, pressure ulcers, urinary retention, and incontinence. Due to a sharp increase in life expectancy and falling birth rates, the world's population is aging quickly. The U.S. Census Bureau estimated that 8.5%, or 617.1 million, of the 7.3 billion people in the world in 2016 were 65 or older. In 15 years, the population of seniors is expected to rise by more than 60%. According to estimates, there are approximately 1 billion older people, or 12.0% of all people worldwide. In addition, according to data released by the Centers for Disease Control and Prevention, UTIs are contracted in hospitals.

Furthermore, catheters are used by about 75% of hospitalized patients to remove urine or other bodily fluids. However, this causes UTIs to develop in roughly 15% to 20% of hospitalized patients. Urinary tract infections and asymptomatic bacteriuria, common in older adults, are brought on by the prolonged use of catheters. Coating catheters is beneficial in preventing these infections. Therefore, it is anticipated that the growing elderly population and rising coating catheter demand will spur market expansion during the forecast period.

Global Catheter Coating Market Restraints

High Cost of Raw Materials

The unpredictable increase in the price of coating materials has an impact on coating manufacturers all over the world. Increased costs are anticipated to result in lower coatings sector margins, leading to more consolidation to increase profitability. Furthermore, because of how the supply chains for coating raw materials are set up, even a slight increase in demand puts pressure on the supply of some essential chemicals, affecting prices. Therefore, increased raw material costs are anticipated to limit market expansion.

Global Catheter Coating Market Opportunities

High Potential in Developing Markets

The developing economies of Asia-Pacific and Europe offer lucrative opportunities for market participants. It is expected that increased R&D, innovation, and awareness of coating technologies will have a positive impact on the market. Soon, opportunities for market growth are anticipated to arise from the gradual adoption of catheter coating technologies. Increased awareness of catheter-associated urinary tract infections (CAUTI) and the presence of significant players like B. Braun, Covalon OEM Technologies, Hydromer, and PolyOne Corporation also contribute to the market's growth. Therefore, it is anticipated that the above factors will present various market growth opportunities in developing countries. For companies that provide catheter coating, emerging economies offer lucrative opportunities to grow their businesses.

Regional Analysis

By region, the global catheter coating market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Global Market

North America is the most significant contributor to the global catheter coating market and is expected to grow at a CAGR of 5.60% during the forecast period. North America has experienced the most significant adoption of market technologies due to the ongoing development, accessibility, and availability of catheters for various medical operations and treatments. The report considers the three major North American nations of the United States, Canada, and Mexico. In addition, the U.S. market is predicted to hold the biggest global market share because of the rising prevalence of urinary incontinence and the growing geriatric population. According to projections from the Population Reference Bureau, the number of Americans 65 and older is expected to double in 2019, rising from 52 million in 2018 to 95 million in 2060. Additionally, according to the Urology Care Foundation, 33 million Americans were thought to have an overactive bladder as of 2019. According to their study, urinary incontinence is directly related to an aging population. As a result, the demand for catheters is rising, fueling the expansion of the market in North America.

Europe is expected to grow at a CAGR of 7.20% during the forecast period. Germany, France, the United Kingdom, Italy, and the rest of Europe are the four significant nations covered in the European market. The increase in the prevalence of cardiovascular diseases (CVDs) across Europe is a significant factor driving the European market. According to the European Heart Network, 3.9 million people died from CVDs in Europe and about 1.8 million people in the European Union in 2017. As a result, there is now a higher need for catheters in the area, which will drive the market for catheter coating. In addition, the German market is expanding steadily due to an increase in urinary incontinence cases and bladder weakness in the nation. CVD cases, urinary incontinence, and bladder weakness are anticipated to increase catheter demand in the area, benefiting the catheter coating industry.

Asia-Pacific is expected to grow significantly over the forecast period. Due to its large population base, rising awareness of urinary self-catheters, expanding healthcare infrastructure, and rising demand for intermittent catheters, this region presents lucrative opportunities in the market. Furthermore, the Asia-Pacific region's market is anticipated to grow due to critical manufacturers in the sector, including DSM, Bard Catheters, Allegro Medical, and Looyo. In addition, the prevalence of cardiovascular diseases (CVDs) among the population and rising risks of acute myocardial infarctions in China is anticipated to fuel the growth of the market there, as this prevalence will increase the demand for CVD catheters there.

LAMEA is increasingly developing into a lucrative market due to rising healthcare sector awareness of the market and greater accessibility of catheters. Most Latin American and Middle Eastern nations, particularly Brazil, Argentina, Mexico, Chile, Saudi Arabia, Turkey, and Uruguay, have seen their investment in science and technology as a percentage of GDP grow steadily and consistently over time. Additionally, it is consistent with the investment trends and objectives established by these nations' public and private sectors. Benefits of the market, like corrosion and abrasion resistance, antimicrobial resistance, and durability, encourage medical manufacturers in this region to invest in market technologies, thereby accelerating market growth.

Segmental Analysis

The global catheter coating market is segmented by material and type.

Based on the material, the global market is bifurcated into metal and polymer.

The polymer segment is the highest contributor to the market and is expected to grow at a CAGR of 6.80% during the forecast period. A chemical compound known as a polymer comprises extended, repeated chains of subunits (cellulose, proteins, and nucleic acids). Polymers can come from either a natural or artificial source. The outer and inner surfaces of the catheters are coated with synthetic polymers in polymer coatings. In addition, polyamide, polyvinylidene fluoride, polydimethylsiloxane, polyethylene, polytetrafluoroethylene, polypropylene, polyimide, perylene, poly (methyl methacrylate), and polyurethane are a few of the polymers used in catheter coating. Catheters have polymer coatings to improve biocompatibility and mobility by lowering friction in body tissues. Catheters have polymer coatings that enable intravascular drug delivery and stop microorganism growth on tissue surfaces.

Catheters frequently have tailored and designed surfaces to control how well these devices work. As a result, the coating material can improve catheter efficiency by preventing blood coagulation and biofilm formation. Since most metals have anti-bacterial qualities, they are used to coat catheter material. The most popular metals used in coating are silver, palladium, gold, and copper, among others. In addition, the main benefit of coating a catheter in metal is that it produces a galvanic effect when it meets biological fluids. The microcurrent produced by the galvanic effect reduces microbial adhesion to the catheter and, in turn, the risk of biofilm formation, thereby decreasing catheter-related infections. The metal coating technology is safe and tissue-friendly because the amount of metal used in coating is within the safety limits.

Based on the type, the global market is bifurcated into hydrophilic coatings, drug-eluting coatings, and anti-microbial coatings.

The hydrophilic coatings segment owns the highest market share and is expected to grow at a CAGR of 7.40% during the forecast period. Thin polymer films composed of polyurethane, polyvinylpyrrolidone, polyacrylic acid, polyethylene oxide, polysaccharide materials, or chemically altered polyester make up hydrophilic coatings. These are the most popular coatings for medical devices because they are non-porous. These coatings are biocompatible, long-lasting, and have a low coefficient of friction, which is known to reduce bacterial adhesion. In addition, central venous catheters (CVCs) and peripherally inserted central catheters (PICCs) are two types frequently coated with the hydrophilic coating to reduce inflammation and improve patient safety and comfort.

One of the most frequently coated objects is catheter and catheter guide wires because hydrophilic coatings reduce friction in the arteries and veins. These coatings also enable aqueous interactions, have low friction coefficients, are resistant to solvents, and prevent thrombosis. The demand for hydrophilic coatings for catheters is anticipated to increase due to these advantages over other coating materials.

Drugs are delivered to the affected sites using a catheter and drug-eluting coatings. These are most frequently used for coating catheters in the peripheral artery and cardiovascular procedures. The medications eluted from the catheters reduce infections, stop inflammation, and avoid artery or vein blockages. Additionally, these coatings aid in lowering thrombosis. Companies are also investing in the production of catheters coated in medication to treat various diseases.

Recent Developments

• April 2022- Partnership for the development of a coated CVC catheter for long-term infection control was announced by CEMMA and LipoCoat.
• June 2022- The Brazilian animal nutrition and technology company Prodap, which combines technology offerings, consulting services, and tailored nutritional solutions to promote efficiency and sustainability in animal farming, agreed to be acquired by Royal DSM, a global purpose-led science-based company.